The Supreme Court’s latest action backing President Trump’s firing of an FTC member is likely to reverberate well beyond the Federal Trade Commission. For lawyers tracking the administrative state, the immediate takeaway is not just about one personnel dispute—it is about the Court’s growing willingness to reconsider how much insulation Congress can give independent agencies from presidential control.

That shift matters because many enforcement and rulemaking frameworks rest on the assumption that certain regulators can operate with a measure of independence from the White House.

Congress has already completed a key piece of legal-system business for fiscal year 2026: the Consolidated Appropriations Act, 2026 is now law, including both the Judiciary Appropriations Act, 2026 and the Financial Services and General Government Appropriations Act, 2026. The legislation, H.R. 7148, is not headline-grabbing in the way a major Supreme Court ruling or enforcement action might be. But for lawyers and court watchers, it is highly consequential.

At a basic level, appropriations determine how well the federal judiciary can function.

A new inter partes review filed at the Patent Trial and Appeal Board could be one to watch for companies operating at the intersection of life sciences, nutraceuticals, and consumer health. In IPR2026-00400, the proceeding is captioned Thorne Research, Inc. and was filed on June 22, 2026.

At this early stage, the PTAB docket signals that a patent challenge involving Thorne Research is underway, but practitioners should note that key details—including the specific patent claims at issue, the identity of the petitioner and patent owner as reflected in the styled papers, and the precise invalidity combinations asserted—may develop as the record fills out.

A new inter partes review, IPR2026-00400, was filed on June 22, 2026, at the Patent Trial and Appeal Board against Thorne Research, Inc. The proceeding is one to watch for companies operating at the intersection of dietary supplements, formulations, and health-focused consumer products, where patent value often turns on how broadly claims are drafted and how well they withstand validity attacks based on published prior art.

At this stage, the publicly available docket information identifies Thorne Research, Inc. as the patent owner, but practitioners should review the petition and related filings to confirm the specific challenged patent, the real parties in interest, and the exact claims at issue as the record develops.

The legal news cycle does not fully stop for the weekend, and this Sunday’s landscape reflects a familiar reality for practitioners: the most consequential developments often emerge over several days and quickly reshape litigation risk, enforcement expectations, and appellate strategy.

As of June 28, 2026, the biggest U.S. legal stories span multiple fronts rather than a single blockbuster filing.

In a terse entry that simply states “Judgment REVERSED and case REMANDED,” the Supreme Court has disposed of docket No. 24-699 without, at least from the information currently available, a full explanatory opinion in the case details provided. Even so, that kind of action from the Court is significant for litigants and appellate practitioners because it immediately alters the posture of the case and signals that the lower court’s judgment cannot stand.

At the most basic level, reversal means the Supreme Court concluded the decision below was wrong in some material respect.

A new post-grant review, PGR2026-00062, was filed at the Patent Trial and Appeal Board on June 25, 2026, in a matter captioned America Ugreen Limited. While the publicly available docket caption immediately identifies Ugreen as a party, patent professionals will want to watch for the petition, mandatory notices, and patent owner filings to clarify the full party alignment, the challenged claims, and the commercial context behind the dispute.

At this stage, the key takeaway is procedural as much as substantive: a post-grant review is only available for patents subject to the AIA’s first-inventor-to-file regime and allows challengers to press a broader range of invalidity theories than inter partes review.

The Justice Department has announced a sweeping federal prosecution against 15 alleged members and associates of Direct Action Minnesota, a Minneapolis-based activist group the government describes as having antifa ties. According to the DOJ, the defendants face a mix of serious charges, including conspiracy to impede federal officers, interstate stalking and threats, solicitation of violence, assault on federal officers, and destruction of government property.

The matter appears in the District of Minnesota as USA v. Alm, et al, and it stands out not only because of the number of defendants, but also because of the government’s emphasis on alleged coordinated action against federal personnel.

The Federal Deposit Insurance Corporation has proposed a notable pullback in two areas that have shaped large-bank compliance since the post-2008 reform era: resolution planning and deposit insurance assessments. If adopted, the changes would significantly ease “living will” obligations for large banks and reduce annual deposit-insurance costs by an estimated $4 billion.

Although this is not a courtroom dispute, it is the kind of regulatory shift that can drive substantial legal work across the financial sector.

The Federal Trade Commission has given final approval to its order against Illuminate Education, closing out a closely watched enforcement action arising from a data breach that exposed information tied to roughly 10.1 million students. For education companies and the schools that rely on them, the case is a sharp reminder that student-data security is now firmly in regulators’ crosshairs.

According to the FTC, Illuminate failed to reasonably secure sensitive student information, resulting in a breach with sweeping impact.

The U.S. Supreme Court has sided with the Trump administration in a closely watched asylum-processing dispute, overturning a lower-court ruling that had blocked the policy as unlawful. The decision gives the federal government wider room to structure how asylum claims are handled at the border and underscores the Court’s continued attention to the scope of executive authority in immigration enforcement.

At a high level, the case centered on whether the administration’s asylum-processing framework was consistent with governing immigration statutes and the procedural limits imposed by federal law.

The Supreme Court’s June 23, 2026 disposition in No. 24-856 is notably concise: the judgment below was reversed and the case remanded. At least from the docket entry provided, the Court has not supplied an accompanying merits opinion in the materials summarized here. Even so, that procedural posture carries real significance for lawyers tracking the case and for practitioners thinking about next steps in the lower courts.

A reversal and remand means the Supreme Court concluded the lower court’s judgment cannot stand and that further proceedings are required.

Tesla has filed a new inter partes review petition at the Patent Trial and Appeal Board, opening IPR2026-00380 on June 18, 2026. At this early stage, the public docket identifies the proceeding under the caption Tesla Inc., but key details that practitioners will want to monitor—including the patent owner, the specific patent number, and the prior-art combinations asserted—may become clearer as the petition and related papers are added to the record.

Even with a limited docket snapshot, the filing itself is notable.

A federal jury has found short seller Andrew Left guilty of securities fraud, delivering a notable win for the U.S. Department of Justice in a criminal case closely watched by the securities bar, hedge funds, issuers, and compliance teams. Prosecutors alleged that Left used his public commentary to move stock prices while privately trading in ways that conflicted with the market-facing views he was promoting.

The verdict is significant because it pushes market-manipulation enforcement beyond the familiar civil playbook and into criminal territory.

A June 17, 2026 filing in the Fourth Circuit puts a familiar but strategically significant appellate issue front and center: whether an appeal should be dismissed before the merits briefing even begins. In No. 25, appellees Debra Campbell, the City of Asheville, and Esther Elizabeth Manheimer moved to dismiss the appeal in Case No. 26-1014, asking the court to terminate the proceeding at the outset rather than allow it to move forward on a full briefing schedule.

Although the short docket entry does not itself spell out every ground raised, motions like this typically target threshold defects that go to the appellate court’s power to hear the case at all.